Logo image of ATEX

ANTERIX INC (ATEX) Stock Fundamental Analysis

NASDAQ:ATEX - Nasdaq - US03676C1009 - Common Stock - Currency: USD

26.63  -0.69 (-2.53%)

Fundamental Rating

3

Taking everything into account, ATEX scores 3 out of 10 in our fundamental rating. ATEX was compared to 33 industry peers in the Diversified Telecommunication Services industry. The financial health of ATEX is average, but there are quite some concerns on its profitability. ATEX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ATEX had negative earnings in the past year.
ATEX had a negative operating cash flow in the past year.
ATEX had negative earnings in each of the past 5 years.
In multiple years ATEX reported negative operating cash flow during the last 5 years.
ATEX Yearly Net Income VS EBIT VS OCF VS FCFATEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -9.18%, ATEX is doing worse than 90.91% of the companies in the same industry.
ATEX has a worse Return On Equity (-20.72%) than 72.73% of its industry peers.
Industry RankSector Rank
ROA -9.18%
ROE -20.72%
ROIC N/A
ROA(3y)-7.39%
ROA(5y)-11.55%
ROE(3y)-11.63%
ROE(5y)-15.17%
ROIC(3y)N/A
ROIC(5y)N/A
ATEX Yearly ROA, ROE, ROICATEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

ATEX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ATEX Yearly Profit, Operating, Gross MarginsATEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K

More info and screens

6

2. Health

2.1 Basic Checks

ATEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
ATEX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ATEX has more shares outstanding
ATEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ATEX Yearly Shares OutstandingATEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ATEX Yearly Total Debt VS Total AssetsATEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

ATEX has an Altman-Z score of -0.47. This is a bad value and indicates that ATEX is not financially healthy and even has some risk of bankruptcy.
ATEX's Altman-Z score of -0.47 is on the low side compared to the rest of the industry. ATEX is outperformed by 84.85% of its industry peers.
ATEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.47
ROIC/WACCN/A
WACC9.05%
ATEX Yearly LT Debt VS Equity VS FCFATEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

ATEX has a Current Ratio of 1.65. This is a normal value and indicates that ATEX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.65, ATEX belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
A Quick Ratio of 1.65 indicates that ATEX should not have too much problems paying its short term obligations.
The Quick ratio of ATEX (1.65) is better than 84.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.65
ATEX Yearly Current Assets VS Current LiabilitesATEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

ATEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -454.35%.
ATEX shows a strong growth in Revenue. In the last year, the Revenue has grown by 66.68%.
ATEX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.40% yearly.
EPS 1Y (TTM)-454.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1950%
Revenue 1Y (TTM)66.68%
Revenue growth 3Y65.77%
Revenue growth 5Y-8.4%
Sales Q2Q%23.21%

3.2 Future

Based on estimates for the next years, ATEX will show a very negative growth in Earnings Per Share. The EPS will decrease by -22.81% on average per year.
ATEX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.56% yearly.
EPS Next Y-82.11%
EPS Next 2Y4%
EPS Next 3Y-22.81%
EPS Next 5YN/A
Revenue Next Year36.61%
Revenue Next 2Y18.53%
Revenue Next 3Y30.56%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ATEX Yearly Revenue VS EstimatesATEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
ATEX Yearly EPS VS EstimatesATEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ATEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ATEX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATEX Price Earnings VS Forward Price EarningsATEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATEX Per share dataATEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

ATEX's earnings are expected to decrease with -22.81% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4%
EPS Next 3Y-22.81%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ATEX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANTERIX INC

NASDAQ:ATEX (6/13/2025, 10:31:04 AM)

26.63

-0.69 (-2.53%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)02-11 2025-02-11/amc
Earnings (Next)06-24 2025-06-24/amc
Inst Owners86.5%
Inst Owner Change4.78%
Ins Owners1.73%
Ins Owner Change-1.96%
Market Cap495.05M
Analysts82.22
Price Target89.25 (235.15%)
Short Float %4.29%
Short Ratio5.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)78.24%
Min EPS beat(2)-14.66%
Max EPS beat(2)171.14%
EPS beat(4)1
Avg EPS beat(4)13.25%
Min EPS beat(4)-83.01%
Max EPS beat(4)171.14%
EPS beat(8)5
Avg EPS beat(8)63.41%
EPS beat(12)7
Avg EPS beat(12)16.89%
EPS beat(16)9
Avg EPS beat(16)12.85%
Revenue beat(2)0
Avg Revenue beat(2)-13.83%
Min Revenue beat(2)-14.71%
Max Revenue beat(2)-12.96%
Revenue beat(4)0
Avg Revenue beat(4)-16.2%
Min Revenue beat(4)-32.26%
Max Revenue beat(4)-4.87%
Revenue beat(8)1
Avg Revenue beat(8)-18.35%
Revenue beat(12)2
Avg Revenue beat(12)-13.91%
Revenue beat(16)4
Avg Revenue beat(16)-13.15%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 83.88
P/FCF N/A
P/OCF N/A
P/B 3.42
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.63
EYN/A
EPS(NY)-0.8
Fwd EYN/A
FCF(TTM)-1.16
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS0.32
BVpS7.79
TBVpS-5.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.18%
ROE -20.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.39%
ROA(5y)-11.55%
ROE(3y)-11.63%
ROE(5y)-15.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2250.98%
Cap/Sales 252.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.65
Altman-Z -0.47
F-Score4
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)1951.72%
Cap/Depr(5y)1293.44%
Cap/Sales(3y)1454.89%
Cap/Sales(5y)1277.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-454.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1950%
EPS Next Y-82.11%
EPS Next 2Y4%
EPS Next 3Y-22.81%
EPS Next 5YN/A
Revenue 1Y (TTM)66.68%
Revenue growth 3Y65.77%
Revenue growth 5Y-8.4%
Sales Q2Q%23.21%
Revenue Next Year36.61%
Revenue Next 2Y18.53%
Revenue Next 3Y30.56%
Revenue Next 5YN/A
EBIT growth 1Y4.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-503.81%
EBIT Next 3Y-55.59%
EBIT Next 5YN/A
FCF growth 1Y63.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y76.38%
OCF growth 3YN/A
OCF growth 5YN/A